Key Metrics
5.9
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
< 0.001
Eigenfactor
Eigenfactor
Eigenfactor Score measures the number of times articles from the journal published in the past five years have been cited. This does not include self citations.
< 5
Impact Factor
Impact Factor
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
Q3
Oncology
SJR
- Q2 Oncology
- Q2 Drug Discovery
- Q3 Cancer Research
- Q2 Pharmacology (medical)
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
0.9
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
Topics Covered
- Breast cancer
- Clinical trial
- Chitosan
- ATP-binding cassette transporter
- Progression-free survival
- Lung cancer
- Triptolide
- Predictability
- Drug delivery
- Polymeric nanoparticles
- Anti-inflammatory
- Metabolic stability
- Ovarian cancer
- Colorectal cancer
- MACF1
- DNA methylation
- Germ cell tumors
- Bufalin
- Clinical significance
- Polyethylene glycol
Journal Specifications
| Overview | |
| Publisher | BENTHAM SCIENCE PUBL LTD |
| Language | English |
| Frequency | Quarterly |
| General Details | |
| Language | English |
| Frequency | Quarterly |
| Publication Start Year | 2006 |
| Publisher URL | Visit website |
| Website URL | Visit website |
Planning to publish in Recent Patents on Anti-Cancer Drug Discovery ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Advanced Strategies of CAR-T Cell Therapy in Solid Tumors and Hematological Malignancies.
- 1 Dec 24
- Recent patents on anti-cancer drug discovery
-
Full paper
CK2B is a Prognostic Biomarker and a Potential Drug Target for Hepatocellular Carcinoma.
- 1 Dec 24
- Recent patents on anti-cancer drug discovery
-
Full paper
The Clinical Significance and Prognostic Value of ALDH1 Expression in Non-small Cell Lung Cancer: A Systematic Review and Meta-analysis.
- 1 Dec 24
- Recent patents on anti-cancer drug discovery
-
Full paper
Acknowledgements to Reviewers
- 1 Dec 24
- Recent Patents on Anti-Cancer Drug Discovery
-
Full paper
Integrating Bioinformatics and Drug Sensitivity Analyses to Identify Molecular Characteristics Associated with Targeting Necroptosis in Breast Cancer and their Clinical Prognostic Significance.
- 1 Dec 24
- Recent patents on anti-cancer drug discovery
-
Full paper
Patent Selections
- 1 Dec 24
- Recent Patents on Anti-Cancer Drug Discovery
Scite analysis
Powered by scite_
779 articles received 7.6k citations see all
- 95 Supporting
- 7,449 Mentioning
- 3 Contrasting
Editorial notices
- 0 Retractions
- 0 Withdrawals
- 0 Corrections
- 0 Errata
- 0 Expression of Concern
FAQs
How long has Recent Patents on Anti-Cancer Drug Discovery been actively publishing?
Recent Patents on Anti-Cancer Drug Discovery has been in operation since 2006 till date.
What is the publishing frequency of Recent Patents on Anti-Cancer Drug Discovery ?
Recent Patents on Anti-Cancer Drug Discovery published with a Quarterly frequency.
How many articles did Recent Patents on Anti-Cancer Drug Discovery publish last years ?
In 2023, Recent Patents on Anti-Cancer Drug Discovery published 53 articles.
What is the eISSN & pISSN for Recent Patents on Anti-Cancer Drug Discovery ?
For Recent Patents on Anti-Cancer Drug Discovery,eISSN is 2212-3970 and pISSN is1574-8928.
What is Citescore for Recent Patents on Anti-Cancer Drug Discovery ?
Citescore for Recent Patents on Anti-Cancer Drug Discovery is 5.9.
What is SNIP score for Recent Patents on Anti-Cancer Drug Discovery ?
SNIP score for Recent Patents on Anti-Cancer Drug Discovery is 0.9.
What is the SJR for Recent Patents on Anti-Cancer Drug Discovery ?
SJR for Recent Patents on Anti-Cancer Drug Discovery is Q3.
Who is the publisher of Recent Patents on Anti-Cancer Drug Discovery ?
BENTHAM SCIENCE PUBL LTD is the publisher of Recent Patents on Anti-Cancer Drug Discovery.